Schulz KF, Grimes DA, 2002: Blinding in randomisedtrials: hiding who got what, Lancet, vol 3599307, pg 696 700. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD,Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K, 2009: Apragmatic explanatory continuum indicator abstract PRECIS: programming help tool computing device science assignment help helptrial designers, Journal of Clinical Epidemiology, vol 625,pg 464 475. Tudur Smith C, Hickey H, Clarke M, Blazeby J, Williamson P,2014: The trials methodological analysis agenda: results from programming help prioritysetting recreation Trials, vol 151, pg 32. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez GeaV, Aracil C, Graupera I, Poca M, Alvarez Urturi C, Gordillo J, Guarner ArgenteC, Santalo M, Muniz E, Guarner C, 2013: Transfusion innovations for acuteupper gastrointestinal bleeding, N Engl J Med, vol 3681 ,pg 11 21. Wright S, Duncombe P, Altman DG, 2012: Assessment ofblinding desktop technological know-how task help treatment allocation in reports of programming help hashish based medicineSativex R in individuals with varied sclerosis: programming help new method, Trials, vol13, pg 189. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG,Gluud C, Martin RM, Wood AJ, Sterne JA, 2008: Empirical evidence of biasin treatment effect estimates in managed trials with various interventionsand effects: meta epidemiological study, BMJ, vol 3367644,pg 601 605.